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Abstract
 
Purpose
 
To characterize the timing and extent of functional recovery in healthy canine 
eyes exposed to acute elevation of intraocular pressure (IOP).
 
Methods
 
Acute elevation of IOP was induced in 14 healthy Beagles by elevating IOP 
above the levels of systolic blood pressure for 60 min (average elevation was between 100 
and 160 mmHg). Menace, dazzle and pupillary light reﬂexes (PLR) were tested at 1, 7, 14 
and 28 days post elevation. Optical coherence tomography was used to evaluate retinal 
thickness preoperatively and at 15 and 30 days post elevation.
 
Results
 
One day post elevation all animals were blind in the operated eye (no positive 
menace), 5/14 had positive PLR and 10/14 had positive dazzle response. Seven days post 
elevation 4/14 animals had positive menace response and all animals (14/14) had positive 
dazzle and PLR responses. Fourteen and 28 days post elevation all animals had positive 
menace, PLR and dazzle responses. Optical coherence tomography analysis revealed 
signiﬁcant thinning of the inferior retina (pre elevation: 156.3 
 
±
 
 4.8 
 
µ
 
m; 15 days post 
elevation:  125 
 
±
 
 10.4 
 
µ
 
m; 30 days post elevation 123 
 
±
 
 11.9 
 
µ
 
m; 
 
P
 
 
 
<
 
 0.01, 
 

 
). The 
superior retina, however, did not show any detectable decrease in thickness compared to 
control eyes (pre elevation: 193.8 
 
±
 
 2.6 
 
µ
 
m; 15 days post elevation: 176.9 
 
±
 
 8.5 
 
µ
 
m; 
30 days post elevation 176.9 
 
±
 
 7 
 
µ
 
m; 
 
P 
 
=
 
 0.057, 
 

 
).
 
Conclusions
 
Detailed functional and morphologic analysis revealed precise information 
about retinal damage after acute elevation of IOP. Canine retina has the capacity to 
recover at least some visual function even at 14 days after acute elevation of the IOP. 
More aggressive medical and surgical treatment of canine glaucomatous patients may be 
indicated despite complete loss of visual function, PLR and dazzle responses in early days 
after development of an acute glaucomatous attack.
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INTRODUCTION
 
Glaucoma is one of the most frequent blinding diseases in
dogs. Numerous etiologies have been established as a cause
of glaucoma. However, the most frequently used classiﬁca-
tions of canine glaucoma are based on characterization of
abnormalities in the aqueous humor outﬂow pathways.
 
1–8
 
Primary glaucoma is a disease characterized by abnormal
structure of the aqueous humor outﬂow pathways, is most
likely a result of a hereditary genetic abnormality,
 
8–11
 
 and is
frequently characterized by the presence of narrow or closed
iridocorneal angles or an abnormally narrow or closed ciliary
cleft.
 
9,12–16
 
 In some dog breeds gonioscopic examination does
not reveal narrowing or closure of the iridocorneal angle.
However, abnormalities in the pectinate ligament structure
or posterior aqueous humor outﬂow structures, such as
trabecular meshwork endothelial cells and collector channels,
have been proposed as possible causes for increased aqueous
humor outﬂow resistance.
 
3,17–24
 
 Secondary glaucoma can
be a result of chronic intraocular inﬂammation (primary or
secondary to intraocular surgery), neoplasia, pigment dis-
persion, lens instability, trauma, retinal detachment and/or
intraocular hemorrhage.
 
2,4,25–31
 
Regardless of the cause of glaucoma, elevated intraocular
pressure (IOP) is considered the major factor causing retinal
neuronal damage. Elevated IOP may cause abnormalities in
 102
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retinal and optic nerve oxygenation and, in combination
with direct mechanical effects, may result in retinal degener-
ative changes.
 
32–34
 
 Glaucomatous conditions characterized
by degenerative retinal ganglion cell death in the absence of
elevated IOP have not been recognized in canine patients. In
veterinary patients reduction of IOP is the major therapeutic
strategy for the treatment of glaucoma, while prophylactic
treatment with different antiglaucoma medications signiﬁcantly
delays the onset of symptoms of disease in fellow normotensive
eyes in glaucomatous dogs that have not developed elevated
intraocular pressure.
 
35–43
 
 While glaucoma in human patients
is usually not associated with clinical signs of ocular pain and
discomfort, glaucoma in veterinary patients is usually
recognized when aggressive clinical signs of the disease are
present. These are usually the result of extremely high IOP
and are accompanied by excessive ocular discomfort. While
numerous studies in human patients have described
methodologies for evaluation of functional outcomes in
glaucomatous patients, similar prognostic data are sparsely
reported in the veterinary literature.
 
44,45
 
 Considering the
frequently poor prognosis and the associated long-term
management, along with medical and surgical treatment costs,
needed to preserve vision of canine glaucomatous patients,
there is a great need for descriptions of reliable prognostic
factors to determine visual outcome in canine glaucomatous
patients. The main purpose of this study was to establish
objective parameters that can help determine the potential
for visual recovery in normal canine eyes exposed to acute
and short-term elevation of IOP by using menace, dazzle
(photopic blink reﬂex) and pupil light reﬂex (PLR) response.
 
MATERIALS AND METHODS
 
All animal studies were conducted in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Visual Research and the Iowa State University Committee
on Animal Care.
Fourteen healthy dogs (Beagles) of 6 months of age were
used in this study. An ocular examination (slit-lamp bio-
microscopy, IOP measurements, indirect ophthalmoscopy) was
performed on all animals to rule out any possible presence of
ocular disease before inclusion in the study.
 
Functional testing
 
Pupil light reﬂex and dazzle response were evaluated by use of
a custom-made ﬁber-optic light source with a maximal output
light intensity of 2000 kcd/m
 
2
 
 (BioMed Vision Technologies,
Ames, IA, USA) pre IOP elevation and at 1, 3, 7, 14 and 28
days post elevation. Animals were dark adapted for 1 min
before testing responses. Because of the possible effect of
ischemia on the iris sphincter muscle of the operated eye,
only indirect pupil light responses were evaluated (light stimulus
was delivered to the operated eye, while the pupil response
was observed from the nonoperated, control eye). Dazzle
responses were evaluated by observing positive blink reﬂex
of the operated eye when light stimulus was applied for 5 s.
Menace response was tested by eliciting palpebral responses in
the control and operated eye, then eliciting the menace response
in the control (nonoperated eye), and ﬁnally by eliciting a response
from the operated eye by using a hand motion toward the
eye from different directions (temporal, frontal and nasal).
 
Acute elevation of the intraocular pressure in dogs
 
Dogs were anesthetized with halothane 2.5% and a mixture
of nitrous oxide and oxygen (30 : 70 ratio) and body temperature
was maintained using a heating pad. The pupils were dilated
with topical 10% phenylephrine hydrochloride (Ak-dilate™,
Akorn Inc., Buffalo Grove, IL, USA) and 1% tropicamide
(Tropicamide, Falcon Pharmaceuticals, Forth Worth, TX, USA).
Prior to anterior chamber cannulation the eye was surgically
prepped and the 0.5% propracaine hydrochloride (Falcon
Pharmaceuticals, Forth Worth, TX, USA) was instilled. The
anterior chamber was cannulated with a 25-gauge needle
connected to a reservoir containing 0.9% NaCl. The IOP in
experimental eyes was controlled by adjusting the height of the
reservoir to maintain a level of systolic blood pressure for 60 min.
The systolic blood pressure was evaluated with an ultrasonic
Doppler ﬂow detector (Model 811-L, Parks Medical Electronics
Inc., Las Vegas, NV, USA) every 5 min. The average elevation
of intraocular pressure was between 100 and 160 mmHg. After
60 min, the needle was removed from the anterior chamber
and topical antibiotic ointment (Vetropolycin, Pharmaderm
Inc., Melville, NY, USA) was applied on the cornea. Post-
operative treatment included one dose of hydromorphone HCl
(0.1 mg/kg, Dilaudid, Abbott Laboratories, Lake Forest, IL,
USA) subcutaneously and application of topical antibiotic
ointment to the operated eye twice daily for 2 days.
 
Optical coherence tomography
 
Optical coherence tomography analysis was performed using
an optical coherence tomography scanner (OCT-1) unit (Carl
Zeiss Meditec Inc., Dublin, CA, USA) in eight dogs.
Dogs were anesthetized with halothane 2.5% and a mixture
of nitrous oxide and oxygen (30 : 70 ratio), and body temper-
ature was maintained using a heating pad. Neuromuscular
paralysis was achieved using intravenous atracurium besylate
(0.2 mg/kg BW, Bedford Laboratories, Bedford, OH, USA)
and mechanical positive pressure ventilation was established
to provide respiratory support and maintain oxygen saturation
above 95%. The pupils were dilated with topical 10% phe-
nylephrine hydrochloride and 1% tropicamide. Corneas were
kept moist by using eye wash solution every 30–60 s to avoid
corneal dessication, which can signiﬁcantly affect quality of
OCT scans. Linear scans were performed in the dorsolateral
retinal region (area centralis, tapetal retina) and inferiolateral
region (nontapetal retina) to obtain retinal thickness data
preoperatively, and at 15 and 30 days post elevation.
 
Statistical analysis
 
Statistical analysis was performed by using 
 

 
 test with
the GraphPad (GraphPad, San Diego, CA, USA) software.
A 
 
P
 
-value of 
 
<
 
 0.05 was considered signiﬁcant.
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RESULTS
 
Functional analysis
 
Analysis of the photopic blink (dazzle) response revealed
recovery in 10 dogs 1 day post elevation, while all dogs dis-
played a positive dazzle response at 7, 14 and 28 days post
elevation (Fig. 1). Analysis of PLR activity showed recovery
of responses in ﬁve dogs 1 day post elevation, while all dogs
had positive responses (of variable intensities) at 7, 14 and
28 days post elevation (Fig. 2). Analysis of the menace
response showed the slowest recovery dynamics compared
to dazzle and PLR responses. Menace response was absent in
all animals 1 day post elevation, recovered in four animals
at 7 days post elevation and was present in all animals at 14
and 28 days post elevation (Fig. 3).
 
Optical coherence tomography
 
Optical coherence tomography analysis showed a small
but signiﬁcant thinning of the nontapetal retina at 15 and
30 days post elevation compared to preoperative values (pre
elevation: 156.3 
 
±
 
 4.8 
 
µ
 
m; 15 days post elevation: 125 
 
±
 
 10.4 
 
µ
 
m;
30 days post elevation: 123 
 
±
 
 11.9 
 
µ
 
m; 
 
P 
 
=
 
 0.0024, 
 

 
,
Fig. 4). While total retinal thickness data for the tapetal
retina showed a trend of retinal thinning, statistical analysis
revealed no signiﬁcant difference at 15 and 30 days post
elevation compared to the preoperative values (pre elevation:
193.8 
 
±
 
 2.6 
 
µ
 
m; 15 days post elevation: 176.9 
 
±
 
 8.5 
 
µ
 
m; 30 days
post elevation: 176.9 
 
±
 
 7 
 
µ
 
m; 
 
P 
 
=
 
 0.057, 
 

 
, Fig. 4). Indi-
vidual dog data for different time points are shown in Table 1.
Figure 1. Recovery dynamics of dazzle response. Seven days after 
acute ischemic insult all animals recovered dazzle response.
Figure 2. Recovery dynamics of the PLR response. Seven days after 
acute ischemic insult all animals recovered PLR response, despite only 
ﬁve animals having positive response 1 day post elevation.
Figure 3. Recovery dynamics of visual function. Fourteen days after 
acute ischemic insult all animals had positive menace response. While 
all animals recovered dazzle and PLR responses at 7 days after acute 
elevation of IOP, only four animals had detectable recovery of some 
visual function.
Figure 4. Optical coherence tomography analysis showed signiﬁcant 
thinning of the inferior retina after acute elevation of IOP.
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DISCUSSION
 
Canine glaucoma is a blinding disease in which aggressive
medical and/or surgical therapy may restore vision. As long-
term preservation of vision is directly related to the control
of intraocular pressure, aggressive medical and surgical
strategies usually result in better visual outcomes, if treatment
is initiated soon after clinical symptoms of blindness have
developed. Glaucomatous canine patients are frequently
presented as emergencies with severely impaired or com-
pletely absent visual function in the affected eye. While
currently available medical and surgical strategies can decrease
acutely elevated IOP, the major concern for owners and
veterinary ophthalmologists remains the prospect of visual
recovery after ocular hypertensive episodes. Obviously, a
poor prognosis for visual recovery will guide the decision
toward more conservative treatment where the ultimate goal
is alleviation of ocular discomfort rather than preservation
of visual function. Traditionally, absence of dazzle and PLR
responses in canine patients, once IOP has decreased to
normal levels, are considered poor prognostic factors for
visual recovery. This frequently guides ophthalmologists and
owners to pursue eye salvaging/pain-alleviating procedures.
This is particularly so in cases where long-term medical IOP
control is poor without introduction of surgical procedures
(diode laser treatment and/or shunt placement).
 
42,46,47
 
Dazzle and pupil light reﬂex responses are nonvisual
responses due to subcortical localization of their centers,
while menace response is mediated via activation of the visual
cortex and represents a crude estimate of visual function.
Dazzle, PLR and menace responses are mediated by photo-
sensitive pigments in outer segments of photoreceptors
(opsins) and speciﬁc populations of intrinsically photosensitive
RGCs (melanopsin, cryptochromes).
 
48–50
 
 This study dem-
onstrates that the healthy canine retina has a remarkable
physiologic capacity to recover at least some retinal function
after being exposed to severe elevation of IOP. We have
demonstrated that recovery of dazzle responses was most
robust, followed by recovery of PLR. However, recovery of
some visual function (observed by positive menace response)
even at 14 days after acute elevation of the IOP was relatively
unexpected. While experimental acute elevation of IOP is
not the ideal model for studying canine patients with spon-
taneously occurring glaucoma, complete absence of vision,
PLR and dazzle responses, and predominant structural
deﬁcits in the nontapetal (inferior retina) region are frequently
observed features in canine glaucoma. Previous studies
suggest that severe, acute elevation of intraocular pressure
causes retinal damage by mechanical and ischemic components.
Therefore, a direct comparison of our results with spontane-
ously occurring canine glaucoma, where elevation of IOP
is chronic and never so severe, is not strictly possible.
 
51
 
However, we hypothesize that results of this study can be
extrapolated to some extent to canine glaucomatous patients.
It is our clinical experience that glaucomatous dogs with
complete absence of menace, dazzle and PLR responses can
recover some visual function days or weeks after occurrence
of the glaucomatous attack. This controlled study has
conﬁrmed our clinical observations. More aggressive medical
and surgical therapy for canine glaucomatous patients in the
early days after IOP elevation is therefore warranted despite
complete functional absence of traditionally observed para-
meters such as menace, PLR and dazzle responses.
 
Other objective diagnostic modalities with a prognostic value in 
canine glaucoma
 
The need to quantify structural damage to the optic nerve
has led to the development of imaging devices for measuring
the number and distribution of retinal ganglion cell (RGC)
axons. The imaging techniques presently available for
measuring the number of retinal cells are optical coherence
tomography (OCT), retinal thickness analysis (RTA), and
scanning laser polarimetry (Gdx); the latter measures retinal
birefringence (retinal depolarization of light).
 
52–55
 
 OCT
provides the most direct measurement of the thickness of the
inner superﬁcial retinal layer where the RGC axons are
located, and has been used extensively in the diagnosis of
early glaucoma.
 
52,54,56
 
 Furthermore, OCT has been used
extensively to obtain detailed topographic ‘
 
in vivo
 
 histology’
of retina in different ocular diseases.
 
57–60
 
 In this study OCT
was used to provide the primary retinal structural information
in canine eyes after acute elevation of IOP. We previously
Table 1 Optical coherence tomography data (thickness is expressed in µm)
Dog 
number
Preop 
nontapetal 
Preop 
tapetal 
15 days 
nontapetal
15 days 
tapetal
30 days 
nontapetal
30 days 
tapetal
1 165 180 140 200 150 190
2 165 190 150 200 130 190
3 175 200 150 200 160 200
4 150 200 125 165 120 160
5 155 200 155 190 165 200
6 130 190 100 170 80 160
7 160 190 100 150 90 160
8 150 200 80 140 90 155
Tapetal retinal scans were performed through the area centralis (dorsotemporal region of the optic nerve), while the nontapetal retinal scans were 
performed through the nontapetal region (ventrotemporal region of the optic nerve).
 © 2007 American College of Veterinary Ophthalmologists, 
 
Veterinary Ophthalmology
 
, 
 
10
 
, 101–107
 
                        
 
105
 
used morphometric analysis of retinal tissue sections and
demonstrated signiﬁcant asymmetry between superior and
inferior retina (superior retina is approximately 10–15%
thicker than the inferior retina) in healthy canine eyes. The
same physiologic difference has been conﬁrmed 
 
in vivo
 
 by
using OCT (Fig. 4). In this study we detected signiﬁcant
thinning of the inferior retina after pressure-related insult,
which corresponds to the histologic appearance of canine
glaucomatous eyes. While OCT can be used to monitor pro-
gression of retinal damage in glaucoma or in experimental
models of retina and optic damage, structural imaging can
also be used to obtain better prognostic information about
the status of the optic nerve prior to making any decision
whether or not to pursue more aggressive therapeutic
options for treatment of glaucoma (Fig. 5).
 
CONCLUSIONS
 
We have demonstrated that the canine retina has excellent
potential for visual function recovery even at 14 days after
exposure to a dramatic elevation of intraocular pressure.
Furthermore, we have shown that the absence of dazzle and
PLR responses in the ﬁrst 7 days after a hypertensive insult
does not necessarily rule out functional visual recovery at
later time-points. While this study was performed in healthy
dog eyes, we can draw a possible conclusion that aggressive
medical and surgical treatment for visual recovery should be
pursued in glaucomatous patients for at least 14 days prior to
deciding to convert to salvaging procedures.
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